Abstract
Recently, wide media coverage ensued after it was announced that two research groups, one from the United States and the other Japanese, had individually managed to reprogram human skin cells to transform them into pluripotent cells similar to embryonic cells; these are cells from which different tissue cells may be derived that, in principle, could be used to treat the skin cell donor.